InMode Ltd vs MobilEye Global Inc — how do they compare? InMode Ltd trades at $14.16 (market cap $809.93M), while MobilEye Global Inc trades at $7.16 (market cap $6.00B). The key difference: MobilEye Global Inc is far larger — about 7.4× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and MobilEye Global Inc for 15 Days on average.
| INMD | MBLY | |
|---|---|---|
Market Cap | $809.93M | $6.00B |
Volume | 365,490 | 7,007,849 |
Sector | Health | Consumer Cyclical |
52-Week High | $16.62 | $15.42 |
52-Week Low | $12.76 | $6.56 |
Typical Hold Time | 29 Days | 15 Days |
Enterprise Value | $313.27M | $4.56B |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, up 0.14% on the day, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 earnings of $0.35 per share, beating expectations, and maintains a strong gross profit margin of 76.52%. Recent news includes the launch of Morpheus8 Cool and an unsolicited acquisition offer from Steel Partners at $16.75 per share.
The outlook is mixed: valuation metrics like P/E of 11.63 and EV/EBITDA of 4.48 appear attractive, but declining net income and bearish technicals pose risks. Analyst consensus is divided with 45.45% buy ratings, highlighting potential upside from strategic developments against execution challenges.
Mobileye Global (MBLY) trades at $7.14, down 0.14% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $2.0B in 2026 but faces significant profitability challenges with a -201.49% net income margin. Analyst consensus is mixed with 57.7% buy ratings but a bearish technical outlook from indicators.
The stock presents a high-risk opportunity with substantial upside to the $10.83 consensus target but requires careful monitoring of profitability improvements. Key risks include persistent losses, competitive pressures in autonomous driving, and execution challenges in robotaxi expansion.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →